Results 91 to 100 of about 21,706 (181)

Allopurinol Beyond Gout: Targeting Oxidative Stress and Metabolic Inflammation in Diabetes and Its Complications. [PDF]

Int J Rheum Dis
Qamar F, Vohora D, Sharma M.
europepmc   +1 more source

Exploratory Mediation-Informed Analysis and Dose-Response Analysis of Uric Acid Reduction and Kidney Outcomes in SGLT2 Inhibitor Therapy Compared to Allopurinol. [PDF]

Med Sci (Basel)
Jámbor T, Tallósy SP, Lantos T, Szabó A, Fejes R.   +4 more
europepmc   +1 more source

In Silico Molecular Docking Studies and Xanthine Oxidase Inhibitory Activity of <i>Abies kawakamii</i> Leaf Extract and Its Constituent. [PDF]

Pharmaceuticals (Basel)
Huang CY, Yen PL, Hsu LS, Low JG, Huang YM, Huang SL, Ko CH, Chang HT.   +7 more
europepmc   +1 more source

Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation. [PDF]

Eur Heart J Cardiovasc Pharmacother
Borghi C, Fogacci F, Cicero AFG.
europepmc   +1 more source

Direct quantitative PCR detects genetic biomarkers of antileishmanial drug resistance in clinical samples from dogs with leishmaniosis. [PDF]

BMC Vet Res
Carrasco-Martin M, Viñeta C, Martí-Carreras J, Roura X, Ferrer L, Busquets P, Vila A, Francino O.   +7 more
europepmc   +1 more source

Allopurinol and Alkaline Phosphatase Levels in Patients with Non-Dialysis CKD. [PDF]

J Clin Med
Taskapan H, Taskapan T, Bellasi A, Tam P, Sikaneta T.   +4 more
europepmc   +1 more source

Hyperuricemia is associated with periodontal ligature dysbiosis in a murine model of experimental periodontitis. [PDF]

J Oral Microbiol
Wu Z, Xu T, Zhao L, Zhou Y, Yu T.
europepmc   +1 more source

Network pharmacology-based prediction and experimental validation of the anti-hyperuricemic effects of oolong tea polyphenols. [PDF]

Front Nutr
Lin F, Lu D, Chen J, Lu D, Liu X, Lin S, Wu L, Sun L, Luo Y.   +8 more
europepmc   +1 more source

Gout and allopurinol adherence in newly diagnosed patients and the risk of fractures: a nationwide cohort study. [PDF]

Clin Rheumatol
Doo JH, Yu J, Park SJ, Park SW, Chung J, Kang JH, Park YJ, Shin HY, Han C, Ghang B, Park SM.   +10 more
europepmc   +1 more source

Serum Uric Acid in Chronic Kidney Disease as a Marker of Risk or a Modifiable Driver of Progression: A Systematic Review. [PDF]

Cureus
Cook DE, Gardezi SSH, Sharma E, James J, Singla S, Haroon F, Singla B, Ali AB.   +7 more
europepmc   +1 more source